Rapid Readout: A Phase 3 Prospective, Multicenter, Randomized, Open-Label Trial of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | OncLive
Rapid Readout: A Phase 3 Prospective, Multicenter, Randomi…
Dec 21, 2021
onclive.com
Obinutuzumab + Venetoclax for Frontline CLL | OncLive
Obinutuzumab + Venetoclax for Frontline CLL | OncLive
2 weeks ago
onclive.com
Dr. Kambhampati on Frontline Ibrutinib Plus Obinutuzumab in CLL | OncLive
Dr. Kambhampati on Frontline Ibrutinib Plus Obinutuzumab in CL…
Feb 6, 2019
onclive.com
Dr. O'Connor on the Role of Obinutuzumab in Follicular Lymphoma | OncLive
Dr. O'Connor on the Role of Obinutuzumab in Follicular Lymph…
Nov 28, 2017
onclive.com
Dr. Davids on the Combination of Ibrutinib and Obinutuzumab in CLL
Dr. Davids on the Combination of Ibrutinib and Obinutuzumab in CLL
Jan 3, 2018
onclive.com
Dr Kittai on an Indirect Comparison of Acalabrutinib Plus Obinutuzumab vs Zanubrutinib in CLL/SLL | OncLive
Dr Kittai on an Indirect Comparison of Acalabrutinib Plus Obinutuzum…
Oct 11, 2023
onclive.com
Dr. Ryan on Objectives for Investigating Ibrutinib Plus Obinutuzumab in R/R CLL
Dr. Ryan on Objectives for Investigating Ibrutinib Plus Obinut…
Aug 16, 2022
onclive.com
Dr. Ryan on the Efficacy of Ibrutinib Plus Obinutuzumab in Relapsed/R…
Oct 14, 2022
onclive.com
0:33
FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis
3 months ago
YahooBusiness Wire
3:35
Cancer Immunotherapy
266.5K viewsAug 21, 2020
YouTubeNucleus Medical Media
Obinutuzumab, ibrutinib, and venetoclax in high-risk CLL: the C…
340 viewsFeb 28, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
A Phase II single-arm study of obinutuzumab plus ibrutinib as fro…
141 viewsFeb 26, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Dr. Al-Sawaf on New Safety Signals With Venetoclax/Obinutuzumab in …
Aug 4, 2020
onclive.com
7-year update on a Phase II trial of fixed-duration obinutuzumab, ibru…
350 viewsJun 17, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Impact of prior bendamustine exposure on BsAb treatment outc…
191 viewsDec 13, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
MRD Guided Acalabrutinib, Venetoclax, and Obinutuzumab Th…
429 viewsMar 20, 2024
YouTubeCLL Society
AMPLIFY Trial: Acalabrutinib Plus Venetoclax for CLL
1.2K viewsJan 10, 2025
YouTubeCLL Society
Best Practices for Patients at High Risk for Progression
42 viewsJul 26, 2019
YouTubeTargeted Oncology
2:33
About Cancer Treatment Imbruvica (Ibrutinib)
1.6K viewsNov 3, 2017
YouTubeLighter Side of Cancer
3:20
How Monoclonal Antibodies Treat Cancer
168.3K viewsJun 30, 2020
YouTubeNational Cancer Institute
8:09
Antigen Processing and Presentation (PART I): MHC I Anti…
367.2K viewsNov 14, 2017
YouTubeFrank Lectures
4:36
Obinutuzumab Versus Rituximab in Frontline FL
1.7K viewsJul 18, 2019
YouTubeOncLive
2:03
Venetoclax and obinutuzumab combination therapy for CLL
803 viewsJun 19, 2019
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:07
Pronunciation of the word(s) "Obinutuzumab".
5.3K viewsSep 10, 2020
YouTubeSAYTHEWORD-Learn English Pronunciations …
6:47
Immunotherapy and the side effects
HIGHLY RANKED HOSPITAL
About this channel
YouTubeSunnybrook Hospital
2:20
CLL Whiteboard #2: Mechanisms of Action of Anti-CD20 Agents
10.6K viewsJul 9, 2018
YouTubeHMP Education
8:51
Ibrutinib + Bendamustine/Rituximab in Patients with Previously Treate…
2K viewsNov 16, 2015
YouTubeAmerican Society of Hematology
4:07
Rituximab, Obinutuzumab, and Ofatumumab in CLL
3.8K viewsJun 24, 2015
YouTubeOncLive
2:47
The Mechanism of Action of Immunotherapy for Cancer Treatm…
22.2K viewsJul 30, 2020
YouTubeScientific Animations
3:58
Subcutaneous rituximab versus intravenous rituximab – safety an…
4.5K viewsJan 19, 2017
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder